Skip to main content
. 2016 Mar 17;7(16):22720–22732. doi: 10.18632/oncotarget.8150

Table 2. Univariate and Multivariate Cox regression analysis of the association of various clinicopathological features with progression-free survival in training cohort.

Feature Univariate Multivariate
Hazard ratio (95% CI) P Hazard ratio (95% CI) P
Age (y) ≥ 45 vs < 45 1.213 (0.782–1.883) 0.388
Gender F VSM 0.781 (0.109–5.613) 0.806
Smoking status Present vs Absent 0.967 (0.498–1.876) 0.921
Drinking status Present vs Absent 0.760 (0.478–1.208) 0.245
Pathological differentiation 0.023
Highly 1.000
Moderately 1.767 (1.071–2.914) 0.026
Poorly 2.253 (1.187–4.276) 0.013
Site Non-glottic va Glottic 0.641 (0.412–0.995) 0.047
T stage < 0.001
T1+T2 1.000
T3 2.415 (1.427–4.087) 0.001
T4 2.989 (1.744–5.125) < 0.001
N stage < 0.001 < 0.001
N0 1.000 1.000
N1 2.044 (1.163–3.592) 0.013 1.961 (1.115–3.451) < 0.001
N2 3.862 (2.129–7.007) < 0.001 3.027 (1.659–5.522) 0.019
CISd2 High vs Low 3.761 (2.280–6.203) < 0.001 3.318 (2.030–5.425) < 0.001

Abbreviations: SCC, laryngeal Squamous cell carcinoma (SCC); H, Highly differentiated; M, Moderately differentiated; P, Poorly differentiated; Non-Glottic, Supraglottic and Subglottic; Comprehensive, Surgery and chemotherapy or Surgery and radiotherapy; CISD2, CDGSH iron sulfur domain2.